UBS AM’s GoodRx Holdings GDRX Stock Holding History
Bought
Maintained
Sold
Other funds holding GDRX
FPM
VCM
SLG
VPM
PTC
PGCM
UBS AM's GDRX Position: Q1 2026 in Review
UBS AM increased its GoodRx Holdings (GDRX) stake by 60% in Q1 2026, buying an estimated $145K and bringing the position to 165,037 shares worth $323K. The position accounts for ﹤0.01% of the portfolio, ranked #2643.
UBS AM first reported a position in GDRX in Q4 2020 and has held it in 18 quarters since. The position peaked at $1.36M in Q2 2024. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.
- UBS AM held 165,037 shares of GoodRx Holdings worth $323K as of Q1 2026.
- UBS AM bought 61,736 GoodRx Holdings shares in Q1 2026, an estimated $145K.
- GoodRx Holdings made up ﹤0.01% of UBS AM's portfolio in Q1 2026, its #2643 holding.
- UBS AM first reported a position in GoodRx Holdings in Q4 2020 and has held it in 18 quarters since.
- UBS AM's GoodRx Holdings position peaked at $1.36M in Q2 2024.
- 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.
Based on UBS AM's 13F filing for Q1 2026, filed 13 May 2026.